Therapeutic Goods Administration — Medicine Shortages (TGA)
Therapeutic Goods Administration — Medicine Shortages is the official source of medicine shortage information for Australia (Asia-Pacific). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- www.tga.gov.au
- Country
- Australia
- Notices tracked by Mederti
- 2,182
- Last checked
- 17 Sept 2026
Latest notices from TGA
- Buprenorphine-Hydrochloride — active, high, since 1 Jan 2028 (source)
- Dexamethasone-Sodium-Phosphate — active, high, since 1 Oct 2027 (source)
- Sodium-Valproate — active, high, since 30 Sept 2027 (source)
- Pneumococcal-Purified-Capsular-Polysaccharides — active, high, since 26 Sept 2027 (source)
- Clopidogrel-Hydrogen-Sulfate — active, high, since 1 Jul 2027 (source)
- Deferasirox — active, high, since 30 Jun 2027 (source)
- Voriconazole — active, high, since 1 Jun 2027 (source)
- Benzylpenicillin-Sodium — active, high, since 31 May 2027 (source)
- Ezetimibe — active, high, since 15 May 2027 (source)
- Alprostadil — anticipated, critical, since 1 May 2027 (source)
- Tolvaptan — active, high, since 30 Apr 2027 (source)
- Tadalafil — active, high, since 30 Apr 2027 (source)
- Atazanavir-Sulfate — active, high, since 30 Apr 2027 (source)
- Atazanavir — active, high, since 30 Apr 2027 (source)
- Mannitol — anticipated, critical, since 1 Apr 2027 (source)
Every TGA notice, searchable and alertable
Search Australia's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by Therapeutic Goods Administration — Medicine Shortages. All notices remain the property of their publisher and are linked to the original source.